Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Clinical trial NCT04725994 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04725994
- Sponsor
- Idience Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-28
- Primary completion
- 2026-07-31
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.